A multicenter randomized placebo-controlled trial of intravenous thyroxine for heart-eligible brain-dead organ donors
Abstract Background Brain death frequently induces hemodynamic instability and cardiac stunning. Impairments in cardiac performance are major contributors to hearts from otherwise eligible organ donors not being transplanted. Deficiencies in pituitary hormones (including thyroid-stimulating hormone)...
Guardado en:
Autores principales: | Rajat Dhar, Dean Klinkenberg, Gary Marklin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bad7adb07bd244aab880336b40510960 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Successful En-Bloc Kidney Transplantation from a 5-year-Old Donor with Cerebral Palsy to a 60-Year Old Recipient: A Case Report
por: Mohammad Hatef Khorrami, et al.
Publicado: (2021) -
Circuitous Path to Live Donor Liver Transplantation from the Coordinator’s Perspective
por: Hui-Ying Lin, et al.
Publicado: (2021) -
Manejo del potencial donante cadáver
por: Bugedo,Guillermo, et al.
Publicado: (2014) -
Early Hypertransaminasemia after Kidney Transplantation: Significance and Evolution According to Donor Type
por: Eulàlia Solà-Porta, et al.
Publicado: (2021) -
Remnant renal volume can predict prognosis of remnant renal function in kidney transplantation donors: a prospective observational study
por: Shunta Hori, et al.
Publicado: (2021)